Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 11, Issue 11, Pages 2541-2546

出版商

American Association for Cancer Research (AACR)

发表日期

2012-08-21

DOI

10.1158/1535-7163.mct-12-0358

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now